Repligen Corporation
Repligen Corporation develops bioprocessing technologies and systems for biological drug manufacturing. They offer Protein A ligands, cell culture growth factors, chromatography products, ELISA test kits, and filtration products. Their chromatography products include OPUS columns and CaptivA resins. The company also provides process analytics products under the SoloVPE, FlowVPE, and FlowVPX brands. Products are sold to life sciences, biopharmaceutical, and diagnostics companies, laboratory researchers, and contract manufacturers.
Overview
Sector
Medical Instruments & Supplies
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- With a depreciation Potential of -87.33%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Current Price to Earnings Ratio (209.32) is significantly higher than the sector mean (85.51).
- Earnings are projected to decline (-5.4% per year).
- The company have lower returns than the sector in which it operates. ROIC (4.22%) is significantly lower than the sector mean (8.23%).
- EV/EBITDA (74.08) is significantly higher than the sector mean (47.53).
- EV/EBIT (123.32) is significantly higher than the sector mean.
- The Price to Free Cash Flow ratio (111.62) is significantly higher than the sector mean.
Key Financial Data